This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sicklinger, M.
Right arrow Articles by Neubert, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sicklinger, M.
Right arrow Articles by Neubert, U.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, April 2003, p. 1791-1793, Vol. 41, No. 4
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.4.1791-1793.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

In Vitro Susceptibility Testing of Four Antibiotics against Borrelia burgdorferi: a Comparison of Results for the Three Genospecies Borrelia afzelii, Borrelia garinii, and Borrelia burgdorferi Sensu Stricto

Martin Sicklinger, Ralf Wienecke, and Uwe Neubert*

Department of Dermatology, Ludwig-Maximilians University of Munich, D-80337 Munich, Germany

Received 1 October 2002/ Returned for modification 6 November 2002/ Accepted 20 December 2002

MICs and minimal bactericidal concentrations (MBCs) were evaluated for the four antibiotics azithromycin, amoxicillin, ceftriaxone, and doxycycline against the three main genospecies of Borrelia burgdorferi sensu lato. In MBC testing, statistically significant differences between the genospecies could be found in 7 out of 12 comparative evaluations (P < 0.05).


* Corresponding author. Mailing address: Irisstr. 5, D-82194 Gröbenzell, Germany. Phone: 04981427102. Fax: 0498142592749. E-mail: UES.Neubert{at}gmx.de.


Journal of Clinical Microbiology, April 2003, p. 1791-1793, Vol. 41, No. 4
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.4.1791-1793.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Morgenstern, K., Baljer, G., Norris, D. E., Kraiczy, P., Hanssen-Hubner, C., Hunfeld, K.-P. (2009). In Vitro Susceptibility of Borrelia spielmanii to Antimicrobial Agents Commonly Used for Treatment of Lyme Disease. Antimicrob. Agents Chemother. 53: 1281-1284 [Abstract] [Full Text]  
  • Hodzic, E., Feng, S., Holden, K., Freet, K. J., Barthold, S. W. (2008). Persistence of Borrelia burgdorferi following Antibiotic Treatment in Mice. Antimicrob. Agents Chemother. 52: 1728-1736 [Abstract] [Full Text]  
  • Halperin, J. J., Shapiro, E. D., Logigian, E., Belman, A. L., Dotevall, L., Wormser, G. P., Krupp, L., Gronseth, G., Bever, C. T. Jr (2007). Practice Parameter: Treatment of nervous system Lyme disease (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 69: 91-102 [Abstract] [Full Text]  
  • Hunfeld, K.-P., Ruzic-Sabljic, E., Norris, D. E., Kraiczy, P., Strle, F. (2005). In Vitro Susceptibility Testing of Borrelia burgdorferi Sensu Lato Isolates Cultured from Patients with Erythema Migrans before and after Antimicrobial Chemotherapy. Antimicrob. Agents Chemother. 49: 1294-1301 [Abstract] [Full Text]  
  • Zambrano, M. C., Beklemisheva, A. A., Bryksin, A. V., Newman, S. A., Cabello, F. C. (2004). Borrelia burgdorferi Binds to, Invades, and Colonizes Native Type I Collagen Lattices. Infect. Immun. 72: 3138-3146 [Abstract] [Full Text]  
  • Hunfeld, K.-P., Wichelhaus, T. A., Rodel, R., Acker, G., Brade, V., Kraiczy, P. (2004). Comparison of In Vitro Activities of Ketolides, Macrolides, and an Azalide against the Spirochete Borrelia burgdorferi. Antimicrob. Agents Chemother. 48: 344-347 [Abstract] [Full Text]